Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07457008) titled 'Tolerability & Pharmacokinetics of Ginkgolide B Injection: Single- and Multiple-Ascending Doses in Healthy Subjects' on Feb. 26.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Basic Science. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: West China Second University Hospital
Condition:
Healthy Volunteers
Intervention:
Drug: The 10mg dose group
Drug: The 20mg dose group
Drug: The 30mg dose group
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: July 1, 20...